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The whole-cell patch-clamp technique was used to record 
Ba2+ currents through voltage-activated calcium channels in 
the clonal dorsal root ganglion cell line FI I-B9. The pain- 
producing peptide bradykinin (BK; 100 nr.!) reduced the sus- 
tained Ba*+ current in FI I -B9 cells by 30%. In cultures pre- 
labeled with 3H-arachidonic acid and tested under ionic 
conditions similar to those used for recording Ba*+ currents, 
BK also induced a concentration-dependent, transient, 2.7- 
fold accumulation of 3H-diacylglycerol. Both the elevation of 
3H-diacylglycerol and the inhibition of Ba2+ current began 
within 5 set following BK exposure, and the effective con- 
centration range of BK was similar for the 2 responses. In 
whole-cell recordings, extracellularly applied I -oleoyl-2- 
acetylglycerol (OAG; OS-5 I.LM) mimicked the degree of block 
and occluded the block of sustained current by BK. Another 
protein kinase C (PKC) activator, 1,2-dioctanoylglycerol 
(diC8), blocked 70-100% of sustained current when applied 
intracellularly or extracellularly at 5 PM, whereas extracellular 
application of ethylene glycol dioctanoate (5 MM), an analog 
reported not to stimulate PKC, inhibited only 14% of sus- 
tained current. The pseudosubstrate peptide PKCI9-38 (2 
PM in pipette) and the lipid staurosporine (100 nM in pipette), 
both inhibitors of PKC, reduced the effects of maximal con- 
centrations of OAG or BK by 55-80%. Dynorphin A applied 
intracellularly (2 PM) as a control for nonspecific effects of 
PKCI9-38 did not inhibit the block of sustained current by 
BK. These data are consistent with the hypothesis that BK 
inhibits whole-cell sustained Ba*+ current in FI I-B9 cells 
via a mechanism that involves activation of PKC. 
A variety of hormones and neurotransmitters inhibit Ca*+ action 
potentials and whole-cell Ca2+ current in mammalian neurons 
in vitro (Tsien et al., 1989). Our knowledge about the biochem- 
ical pathways involved in the regulation of neuronal Ca*+ chan- 
nels is, however, incomplete. Rane et al. (1989) have reported 
in chick dorsal root ganglion (DRG) neurons that intracellular 
application of specific inhibitors of protein kinase C (PKC) blocks 
the ability of norepinephrine and PKC activators to reduce the 
whole-cell Ca2+ current. Also, Ewald et al. (1988) have reported 
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that long-term exposure of rat DRG cultures to phorbol esters 
reduces measureable PKC activity and blocks the ability of 
neuropeptide Y to reduce the whole-cell CaZ+ current. Supple- 
mentary evidence includes the ability of exogenous membrane- 
permeable activators of PKC to mimic the agonist-induced in- 
hibition of whole-cell Ca*+ current (Rane and Dunlap, 1986; 
Werz and MacDonald, 1987; Doerner et al., 1988; Marchetti 
and Brown, 1988). Consistent with the potential role of PKC 
in the regulation of neuronal Ca2+ current, norepinephrine (Ha- 
rish et al., 1986) and neuropeptide Y (Ewald et al., 1989) were 
reported to stimulate the release of radiolabeled inositol 1,4,5- 
trisphosphate (IP,) from DRG cultures, implying the concomi- 
tant release of diacylglycerol (DAG), an endogenous activator 
of PKC (Nishizuka, 1984). The involvement of PKC in the 
inhibition of Ca*+ current is controversial, however (Hockberger 
et al., 1989; Bley and Tsien, 1990). 
As reported in rat DRG neurons (Ewald et al., 1989), we found 
that the pain-producing peptide bradykinin (BK) inhibits a frac- 
tion of the whole-cell sustained current through voltage-acti- 
vated CaZ+ channels in a DRG cell line. The clonal line Fl 1 -B9 
is a subclone of the neurofilament-positive F-l 1 cell line pre- 
viously described (France1 et al., 1987a,b; France1 and Dawson, 
1988; Boland and Dingledine, 199Oa). Ba2+ currents in Fl 1 -B9 
cells can be separated into distinct transient and sustained com- 
ponents based on inactivation rates and sensitivity to holding 
potential, as described for the F-l 1 cell line (Boland and Din- 
gledine, 1990b). The sustained component of depolarization- 
activated Ba2+ current is minimally comprised of both L-type 
and N-type currents because one fraction of the current, isolated 
at a holding potential of -40 mV, is completely blocked by 
nimodipine, while another fraction is blocked by w-conotoxin 
GVIA. 
Previous studies on other cell types have reported that BK 
stimulates a variety of second-messenger systems, one or more 
of which might be involved in the regulation of Ca*+ channels 
by BK. There is evidence that BK stimulates cGMP and bio- 
logically active phospholipid metabolites such as DAG, IP,, 
arachidonic acid, leukotrienes, and prostaglandins (for review, 
see Miller, 1987). Indeed, BK was reported to induce a transient 
production of DAG and arachidonic acid in rat DRG cultures 
(Burgess et al., 1989; Gammon et al., 1989) and a transient 
production of IP, and a biphasic production of DAG in F-l 1 
cells (France1 et al., 1987a,b, France1 and Dawson, 1988). Based 
on this evidence and the availability of useful pharmacological 
tools, we tested the hypothesis that BK inhibits whole-cell sus- 
tained Ba*+ current in Fl l-B9 cells via a mechanism that in- 
volves activation of PKC. 
The Journal of Neuroscience, April 1991, 1 I(4) 1141 
Experiments described in this paper were designed to deter- 
mine, first, whether exogenous activators of PKC inhibit the 
Ba2+ current in Fl 1 -B9 cells; second, whether peptide and lipid 
inhibitors of PKC block the effects of the PKC activators and 
BK on the BaZ+ current; and, third, whether BK exposure to 
Fl l-B9 cultures bathed in the external solution used to record 
pharmacologically isolated Ba*+ current induces the production 
of DAG. 
Preliminary accounts of this work have been reported to the 
European Neuroscience Association (Boland and Dingledine, 
1989) and the Society for Neuroscience (Boland et al., 1989). 
Materials and Methods 
Cell culture. Fl l-B9 cells were derived from the neurofilament-positive 
F-l 1 cell line (mouse neuroblastoma N18TG-2 x rat DRG). Stock 
cultures of Fl l-B9 cells were grown in 25-cm2 tissue culture flasks in a 
“growth medium” consisting of Ham’s F- 12 supplemented with 10 mM 
glucose, 12 mM sodium bicarbonate, 15% fetal calf serum (FCS), 100 
/IM hypoxanthine, 0.4 PM aminopterin, and 16 PM thymidine (HAT). 
Cells were maintained in a humidified atmosphere of 6% CO,, 94% air 
at 37°C and were fed every other day. Stock cultures were grown until 
nearly confluent (7-8 d), and then were passed at a 1: 10 dilution. Elec- 
trophysiological experiments were performed on Fl l-B9 cells (passage 
2-l 5) that were plated onto uncoated glass coverslips and fed with either 
growth medium or a “differentiation medium” consisting of Ham’s F- 12 
with 1% FCS, HAT, 0.5 mM dibutyryl CAMP, and 50 rig/ml mouse 
salivarv dand NGF (2.5s). Exoosure of Fl l-B9 cells to differentiation 
medium-for l-3 d enhances the sustained component of Ba*+ current, 
as described previously (Boland and Dingledine, 1990b) but does not 
alter other properties of the Ba*+ current such as stability, activation or 
inactivation parameters, or sensitivity to BK or any other drugs tested 
in this study. No cells were used after more than 3 d exposure to dif- 
ferentiation medium because extensive neurite growth prevented ade- 
quate space clamp. 
Voltage clamp. Macroscopic current through voltage-activated Ca2+ 
channels was recorded using the whole-cell configuration of the patch- 
clamp technique (Hamill et al., 198 1). Voltage pulses were 200 msec in 
duration and were applied every 4-20 sec. Each depolarizing pulse was 
followed by 4-8 hyperpolarizing pulses, each ‘/4-‘/s the amplitude of the 
depolarizing pulse. The currents elicited by hyperpolarizing pulses were 
summed together and used for subtraction of leak and capacitive cur- 
rents. Membrane currents were filtered at 1 kHz using an 8-pole low- 
uass Bessel filter (Freauencv Devices. Haverhill. MA). samnled at >2 
kHz, and stored on a disk. Signals filtered at 20’kHz ‘were stored on a 
videotape recorder. Analysis was performed using in-house programs 
written in C. For all Ba*+ currents, the sustained current was defined as 
the inward current at 19 5 msec and was maximized by test depolariza- 
tions to +20 mV in 30 mM Ba *+. Transient current was defined as the 
peak current minus the sustained component and was maximized near 
0 mV in 30 mM Ba2+. We accepted only those experiments in which 
input resistance was at least 1.0 GR so that leakage current was very 
small. Ba2+ currents were recorded with measured series resistance rang- 
ina from 2 to 10 MR. which uroduced a voltage error of 0.2-1.0 mV 
fo; each 100 pA of current. Because Fl l-B9 cell Ba2+ currents are typ- 
ically less than 400 pA, currents were recorded without series resistance 
compensation, and data points on current-voltage curves were corrected 
for the estimated voltage error induced by the series resistance. Cells 
selected for electrophysiological study were isolated from other cells, 
had nearly spherical cell bodies about 20-30 pm in diameter, and had 
no processes longer than the cell diameter. I f  there was any sign of 
inadequate space clamp or if the calculated voltage error grew larger 
than 5 mV, the experiment was ended. 
Solutions. For the electrophysiological experiments, the standard in- 
ternal solution consisted of(in mM)-120 Cs glutamate, 40 HEPES, 20 
tetraethvlammonium (TEA) Cl. 5 BAPTA. 1 M&l,. 0.1 CaCl,. and 0.1 
GTP. The pH was adjusted to ‘7.3-7.35 with &OH, and the-free Ca2+ 
concentration was calculated to be less than 15 nM. The internal (pipette) 
solution was always kept on ice and used for not longer than 6 hr. The 
standard external solution consisted of (in mM) 30 BaCl,, 80 TEA Cl, 
25 glucose, 20 CsCl, 10 HEPES, and 0.5 PM tetrodotoxin (TTX) and 
was adjusted to pH 7.3-7.35 with CsOH. External solution was warmed 
to room temperature prior to application to the cells. Osmolality of 
each solution was measured using a microosmometer (Precision Sys- 
tems, Natick, MA) and was adjusted with sucrose to 305-320 mOsm. 
Drug application andpreparation. For local drug application to a cell, 
a perfusion pipette with a large tip opening (30-50 pm) was positioned 
close to the cell. The bath volume was 1.0-l .3 ml, and 3 ml of solution 
could be flushed through the system in about 1 min. As indicated by 
the disappearance of Na+ current when perfused with a solution con- 
taining TTX or the block of Ba2+ current by Cd*+, exchange of the 
solution near the cell studied began 8 set after solution change and was 
complete within 30 sec. All experiments were performed at room tem- 
perature (22-25°C). 
The PKC inhibitor PKC19-36 and the peptide dynorphin A were 
dissolved in 0.1 M acetic acid and stored at - 70°C for up to 2 months. 
Aliquots were diluted into the standard internal solution immediately 
prior to use. In order to minimize structural changes of the PKC acti- 
vators, which might account for previous inability to depress Ca*+ cur- 
rent (Hockberger et al., 1989), certain precautions were taken. Lipids 
received from Avanti Polar Lipids or Calbiochem were dissolved in 
HPLC-grade chloroform and stored under argon in solvent-cleaned tubes 
at - 70°C for up to 2 months. Solutions prepared for application to Fl l- 
B9 cells were aliquoted just prior to use, dried under argon, reconstituted 
in dimethylsulfoxide (DMSO) or ethanol, mixed with the standard ex- 
ternal or internal pipette solution, and sonicated for 30 set at 4°C. 
Solutions were then used at room temperature for not longer than 6 hr. 
Application of lipids was always preceeded by bath perfusion with the 
appropriate final concentration of the vehicle. Likewise, recordings per- 
formed with internal application of 1,2-dioctanoylglycerol (diC8) were 
compared to control recordings performed with the appropriate final 
dilution of ethanol in the pipette solution. When the hydrophobic dia- 
cylglycerol analogs were used, the perfusion chamber, solution changing 
apparatus, and perfusion tubing were washed with 10 volume changes 
of absolute ethanol between every cell. 
Diacylglycerol release by exposure to bradykinin. For biochemical 
experiments, Fl 1 -B9 cells (passage 2- 15) were seeded at a 1: 10 dilution 
into 6-well (10 cmZ) plastic culture plates and grown 5-6 d until about 
90% confluent. Cells were then incubated with 3.3 uCi 3H-arachidonic 
acid in 1 ml of growth or differentiation medium for 18-24 hr to label 
the endogenous lipid pool. After the labeling period, culture plates were 
transferred to a 37°C water bath for the biochemical experiments. In 
each experiment, freshly made buffers and dilutions of bradykinin were 
made, and duplicate or triplicate samples were used for each condition 
tested. Unincorporated isotope was removed from the Fl l-B9 cultures 
by washing the culture wells twice with 1 ml of either Hank’s balanced 
salt solution or Eagle’s minimal essential medium. Both solutions were 
serum free, contained 20 mM HEPES, and were adjusted with NaOH 
to pH 7.3-7.4 at 24°C. 
Biochemical experiments were designed to mimic as closely as pos- 
sible the physiological experiments and were therefore performed in an 
external solution containing 30 mM BaCl,. Some experiments were per- 
formed in the same external solution used for the electrophysiological 
experiments (n = 3), and some were performed in an external solution 
in which 100 mM choline chloride replaced Cs and TEA Cl (pH, 7.3- 
7.35 with NaOH; n = 6). The production of diacylglycerol was not 
significantly different for BK (100 nM, 20-set exposure) applied in the 
external solution with or without the K+ channel blockers Cs and TEA 
(2-tailed t test). Thus, biochemical data obtained using either external 
solution are considered together. 
Cells were exposed to the 30 mM Ba*+ solution (control) or bradykinin 
dissolved in the 30 mM Ba2+ solution at concentrations ranging from 1 
nM to 10 PM for time intervals from 5 to 120 sec. Bradykinin exposure 
was terminated by neutral lipid extraction in 2.8 ml of ice-cold chlo- 
roform:methanol(1:2). The entire volume of chloroforrnmethanol and 
the Ba2+ solution in each well were removed to individual glass vials. 
Extracted lipids were analyzed by the method previously described by 
DeGeorge et al. (1986). In brief, 0.9 ml chloroform was-added to each 
tube, the tubes were vortexed and stored at - 20°C for 18-36 hr. Organic 
and aqueous phases of the extracts were clarified by centrifugationy and 
the aqueous phase was removed and discarded. The organic phase was 
concentrated under nitrogen, during which each tube was washed twice 
with an additional 0.5 ml chloroform. The extracts were then dried and 
resuspended in 50-60 ~1 chloroform. 
The entire volume of each extract was spotted on a single lane on a 
heat-activated LK6D silica G plate. The major lipid classes (phospho- 
lipids, phosphatidic acid, triglycerides, diglycerides, monoacylglycer- 
ides, arachidonic acid, and arachidonic acid metabolites) were resolved 
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by development in a solvent system comprised of the upper phase of a 
mixture of ethyl acetate, isooctane, acetic acid, and water (93:47:20: 
100). Chromatography tanks were lined with filter paper and equili- 
brated for 1 hr prior to development. Developed plates were air dried 
for 10 min, sprayed lightly with 2 coats of En3hance, covered with Saran 
wrap, and placed in light-tight envelopes together with Kodak Xomat- 
AR5 x-rav film for 6-7 d at -70°C. Films were then develoned. and 
the autoradiogram was used to locate radiolabeled lipids on ihe thin- 
layer chromatography (TLC) plate. The radiolabeled diacylglycerol spot 
was well separated from other spots and comigrated with unsaturated 
diacylglycerol standards (C 18: 1 or Cl 8:2) as determined by visualization 
with iodine vapor. In 4 experiments, the ratio (R,) of the migration 
distance of the diacylglycerol standard to the migration distance of the 
solvent front was 0.80 ? 0.01, whereas authentic arachidonic acid mi- 
grated with an R, value of 0.71 + 0.01. Other radioactive spots were 
identified based on the migration pattern previously described for this 
system using extracts prepared from rat DRG neurons (Gammon et al., 
1989). Regions of the TLC plate corresponding to spots on the x-ray 
film were individually scraped and transferred to separate scintillation 
vials. Regions without noticeable spots were also scraped into scintil- 
lation vials so that the entire extract was accounted for. Distilled water 
(200 ~1) and scintillation cocktail (5 ml) were added to each vial. Scin- 
tillation vials were then vortexed, left overnight at room temperature, 
vortexed again, and counted by liquid scintillation spectrometry using 
a Packard Tri-Carb 460 CD liquid scintillation system. 
A4uterials. Ham’s F- 12 media was from GIBCO (Grand Island. NY). 
and FCS was from Hazelton (Lenexa, KS). HAT was from Flow Lad: 
oratories (McLean, VA). All other tissue culture reagents were from 
Sigma (St. Louis, MO). Bradykinin, dynorphin A (porcine), and nal- 
oxone were purchased from Peninsula Peptides (Belmont, CA) or Sigma. 
N5 1A glass-for patch pipettes was from Drummond Scientific (Broom- 
all. PA). TTX was from Siema or Calbiochem (San Dieeo. CA). GTP 
was from Boehringer Maniheim Biochemicals (Indianapolis, IN). All 
salts were ofthe highest purity available and were purchased from either 
Alfa (Danvers, MA) or Aldrich (Milwaukee, WI). 3H-arachidonic acid 
(83.6 Ci/mM) and En’hance were obtained from New England Nuclear 
Products (Boston, MA), and unlabeled arachidonic acid was from Sig- 
ma. Silica gel LK6D thin-layer chromatography plates were purchased 
from Whatman Ltd. (Maidston, UK). All organic solvents were pur- 
chased from Fisher or Mallinckrodt and were HPLC grade. Authentic 
diacylglycerol standards and 1 -oleoyl-2-acetylglycerol (OAG) were from 
Avanti Polar Linids (Birmingham. AL) or Calbiochem. 1.2-Dioctanovl- 
glycerol (diC8) and ethylene-glycdl dioctanoate (EGD) were from Mo- 
lecular Probes (Eugene, OR). The pseudosubstrate inhibitor of PKC 
(PKC19-36) was from Auspep (Melbourne, Australia). Staurosporine 
was from Calbiochem. 
Results 
Bradykinin inhibits barium current in the Fl i-B9 subclone 
In 25 of 29 cells recorded with the standard internal pipette 
solution, BK (100 nM) depressed the sustained Ba2+ current by 
29 + 2.0% (mean f SEM; IZ = 25; Fig. 1B). In contrast to the 
block of sustained current by 100 nM BK, the transient current 
was inhibited by only 8.4 + 2.5% (n = 21; Fig. 1A) in cells 
expressing both transient and sustained currents. Four Fl 1 -B9 
cells were considered nonresponders by the criterion that less 
than 10% of the sustained Ba*+ current was blocked by 100 nM 
BK. Thus, 86% of the Fl l-B9 cells demonstrated the inhibition 
of sustained current by BK. 
The degree and concentration dependence of inhibition by 
BK of transient and sustained Ba*+ currents are compared in 
Figure 1. BK always blocked a larger fraction of the sustained 
current than transient current. The IC,, for BK block of both 
currents was about 30 nM (Fig. 1D). The onset of block by BK 
occurred within 5 set after applying BK by pressure ejection in 
a perfusion system that gave complete block of Ba2+ current by 
100 PM Cd2+ within 5 set (n = 3 cells). All other experiments 
used a slower application of extracellularly applied drugs through 
a large pipette positioned close to the cell. Each application of 
BK was not longer than 1 min because maximal block was 
achieved in less than 1 min (usually 25-35 set), and after this 
exposure time, inhibition of Ba2+ currents could be reversed by 
reperfusion with the control external solution (Fig. lA,B). In 3 
cells (12% of the responders), the inhibition of BaZ+ current 
during the continued presence of 100 nM BK appeared to fade 
over the course of a 1 -min application, suggesting desensitiza- 
tion of the response. In 88% of the cells that responded to the 
first application of BK, up to 2 additional applications of BK, 
separated by at least 2 min during a 15-25-min recording, were 
effective in producing inhibition of the sustained current. BK 
inhibition of BaZ+ currents was not associated with a marked 
change in the current kinetics or a shift in the current-voltage 
relationships for the sustained (Fig. 1 B, C) or transient (Fig. 1A) 
currents (n = 5 cells examined over the voltage range of -60 
to +40 or +50 mV). The possible voltage dependence of the 
action of BK was not studied at larger test depolarizations (cf. 
Bean, 1989). All data that follow focus on the inhibition of 
sustained Ba*+ current. 
In contrast to a previous report on DRG neurons (Burgess et 
al., 1989) BK application to Fl l-B9 cells was not accompanied 
by a consistent, substantial change in the holding current at the 
holding potential of -70 mV. Rarely, a small inward current 
(up to 10 PA) accompanied the application of BK, but this effect 
did not recover following the removal of BK, and the small 
current could also be produced occasionally by perfusion with 
control solutions, suggesting that it was simply a perfusion ar- 
tifact. The BK-induced current in DRG neurons is reported to 
be carried primarily by Na+ (Burgess et al., 1989) and thus would 
not be expressed under the ionic conditions used here for re- 
cording BaZ+ currents. Likewise, BK application to the Fl l-B9 
cells did not activate an outward current at the holding potential 
of -70 mV. In the NG108- 15 cell line, BK increases a Ca2+- 
activated K+ conductance (Brown and Higashida, 1988). The 
expression of such a current, however, would not be expected 
under the ionic conditions used here in which K+ currents were 
suppressed by a combination of internal and external Cs+ and 
TEA. 
Effects of activators and inhibitors of protein kinase C 
Activators: OAG and diC8 
Figure 2 compares in the same cell the inhibition of sustained 
Ba*+ current produced by maximal concentrations of BK (100 
nM) and OAG (5 MM), a DAG analog that activates PKC (Nishi- 
zuka, 1984; Ebeling et al., 1985). When tested on the same cell, 
maximal concentrations of OAG reduced the sustained Ba2+ 
current to nearly the same level as that produced by 100 nM 
BK (Fig. 2A,C). Moreover, in the continued presence of 5 KM 
OAG, 100 nM BK produced no further block of the sustained 
current (n = 3 cells), indicating that the effects of the 2 drugs 
were not additive. Effects of extracellularly applied PKC acti- 
vators were measured after a 2-min exposure. This exposure 
time was sufficiently long to produce maximal block by a par- 
ticular concentration of OAG and also allowed partial reversi- 
bility of the block upon returning to perfusion with control 
solutions (Figs. 2A, 3A). Incomplete reversibility of the effects 
of the PKC activators may be due to their hydrophobic nature. 
In some experiments (n = 4 cells), OAG (5 FM) was applied for 
up to 5 min and produced no further change in any component 
of the whole-cell Ba2+ current in Fl l-B9 cells. Depression of 
sustained BaZ+ current in F 11 -B9 cells by OAG was not accom- 
panied by an obvious change in kinetics of the whole-cell BaZ+ 
current (Fig. 2A) or the current-voltage relationship for the sus- 
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Figure 1. BK block of BaZ+ currents 
in Fl 1 -B9 cells. A and B, Current traces 
recorded from the same cell. Inward 
currents were elicited from a holding 
potential of -70 mV with test depo- 
larizations (V,,,) to 0 mV (A) or +20 
mV (B) and represent control Ba*+ cur- 
rents (con), partial block of the currents 
during exposure to 100 nM BK, and 
recovery (ret) of the current 2 min after 
beginning the washout of BK. BK 
blocked 11% of the transient (A) and 
55% of the sustained current (B) in this 
cell. C, Current-voltage curve for the 
sustained current (different cell) record- 
ed in control solution (open circles) and 
after maximum block by 100 nM BK 
(solid circles). D, Dose-response rela- 
tionships for inhibition of transient (tri- 
angles) and sustained (circles) currents 
by BK. All currents were elicited from 
a holding potential of -70 mV, with 
depolarizations to 0 mV (transient) or 
+20 mV (sustained). Each data point 
is the mean + SEM for 3-6 cells, except 
for 100 nM BK, for which n = 21. A 
maximum of 3 concentrations of BK 
were tested on an individual cell. 
tained current (Fig. 2C, y1 = 5 cells examined over the voltage with about 500 nM OAG, which reduced the sustained current 
range of - 60 to + 40 or + 50 mV) as reported by others in DRG by 29 + 6.9% (n = 4). Application of 5 or 50 PM OAG usually 
neurons (Rane and Dunlap, 1986; Marchetti and Brown, 1988). produced no further block (see Fig. 5). 
On individual cells, multiple applications of OAG (up to 5 tested) Figure 3, A and B, compares the inhibition of sustained Ba2+ 
were effective. The sustained BaZ+ current of all 6 cells tested current produced by diC8, a stable DAG analog that activates 
was inhibited by 50-500 nM OAG. Maximum block occurred PKC, and EGD, an analog of diC8 that is reported not to activate 
A no inhibitor 
icon ( 
2 5 OAG 
3 ret 
150 pA 1 
B + 2 @6 PKClQ-36 
100 pA 1 
100 ms 100 ms 
C no inhibitor 
0 +lOO nM BK 
-300 1 
-60 -40 -20 0 20 40 
Vtest (mV) 
Figure 2. Similarity of the inhibition of sustained Ba2+ current by OAG and BK. Ba2+ currents in A and B were elicited by depolarizations to 
+20 mV from a holding potential of -70 mV and represent Ba2+ currents recorded with (A) the control pipette solution or (B) a pipette solution 
containing the protein kinase C inhibitor PKC19-36 (2 PM). Currents were recorded before (I) and during (2) the maximum inhibition produced 
by 1 min exposure to 100 nM BK or 2 min exposure to 5 WM OAG and during partial recoveries (3) 2 min after the washout of BK or OAG. Both 
sets of traces in A are from the same cell, and traces in B are from the same cell. C, Current-voltage relationship for the sustained current (same 
cell as in A) recorded with the control external solution (open circles) or following the maximum block produced by 5 FM OAG (open triangles). 
For comparison, 4 data points for the sustained current recorded after maximum block by 100 nM BK are shown (solid circles). See Figure 1 for 
abbreviations. 
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Figure 3. Inhibition of sustained Ba2+ current by diC8. A and B, Current traces recorded from 2 different Fl l-B9 cells. Currents were elicited 
from a holding potential of -70 mV with test depolarizations (V,,,) to +20 mV and represent control currents (con), partial block of the currents 
during a 2-min exposure to the PKC activator diC8 (5 FM; A) or the inactive analog EGD (5 PM; B), and recovery (ret) of the current 2 min after 
beginning the washout of the drug. Both recordings were made with a control pipette solution (no PKC inhibitor). C, Current-voltage curves for 
the sustained current (same cell as in A) recorded in control external solution (open circles) and after block by 5 PM diC8 (solid circles). D, Comparison 
of the inhibition of sustained current by diC8 and EGD. For diC8, each data point is the mean & SEM for 4-7 cells. For EGD, the solid bar 
represents he mean ? SEM for block of sustained current in 8 cells in the absence of PKC inhibitor. The inhibition of sustained current produced 
by 5 PM diC8 was significantly greater than that produced by 5 KM EGD (p < 0.001, 2-tailed t test). For comparison, the degree of block by 5 or 
50 PM diC8, recorded with 2 PM PKCl9-36 inside the pipette solution, is shown for 4 different cells (open circles). 
PKC (Bishop and Bell, 1986; Ganong et al., 1986). In the pres- 
ence of 5 PM diC8, the sustained current was markedly reduced 
(Fig. 3A), while the same concentration of EGD was much less 
effective (Fig. 3B). EGD at a concentration of 5 PM produced 
14 f 3.8% block (n = 8) of sustained current (Fig. 30, solid 
bar), whereas an equal concentration of the active analog diC8 
produced 71 f 6.8% block (n = 11) of sustained current. Con- 
centration-response curves for the block of sustained Ba2+ cur- 
rent by diC8 (Fig. 30) indicate that maximum block occurred 
with about 50 PM diC8, which reduced the sustained current by 
about 90%. Inhibition of sustained current by diC8 was partially 
or completely reversible upon returning to perfusion with con- 
trol solutions (Fig. 3A). The sustained Ba2+ current of every 
Fl l-B9 cell tested was inhibited by at least 500 nM diC8. De- 
pression of sustained current by diC8 was not accompanied by 
a marked change in the current-voltage relationship (Fig. 3C, 
n = 3 cells examined over the voltage range of -60 to +40 or 
+ 50 mV). Similar to OAG, multiple applications of diC8 were 
effective in producing block of the sustained current. 
Because external application of 5-50 PM diC8 blocked about 
70-90% of the sustained Ba2+ current in Fl 1 -B9 cells, it was of 
interest to determine whether internal application of the highly 
lipid-soluble diC8 would also block sustained current. The in- 
clusion of 5 MM diC8 in the pipette solution blocked 90-100% 
of sustained current in each of 3 cells tested in which the un- 
compensated series resistance was 3-4 MQ (Fig. 4B, solid circle). 
The block produced by internally applied diC8 began 7-10.5 
min after rupture of the patch and was complete in 12-l 8 min 
(Fig. 4A,B). Our observation that maximal block by external 
application of diC8 could be achieved in 90 set suggests a slow 
diffusion of the lipid out of the pipette solution. In one cell, 
internally applied diC8 produced only a 20% block of the sus- 
tained current after 18 min, but in this recording the series 
resistance had climbed to over 20 MO within 10 min, suggesting 
that the pipette was clogged and access to the added diC8 was 
likely impaired. In contrast, in each of 17 control recordings 
using the standard pipette solution plus 0.1% ethanol or 2 PM 
dynorphin, sustained current amplitude was relatively stable 
within the first 18 min after establishing the whole-cell recording 
(Fig. 4B, open square). In these control experiments, no drugs 
were applied externally for the duration of the recording. More- 
over, in recordings from >75 Fl l-B9 cells used in other ex- 
periments, rapid and complete rundown of the sustained current 
was never found under the ionic conditions employed here. In 
some control experiments, a small degree of rundown of sus- 
tained current (approximately 30% reduction after 15-20 min) 
was observed. Thus, OAG was not tested in the pipette solution 
because the maximal effect expected (about 30% inhibition) 
would have been difficult to distinguish from a small degree of 
rundown that occurs in some cells. 
Inhibitors: PKCI 9-36 and staurosporine 
In some experiments, a PKC inhibitor was added to the pipette 
solution, and cells were held for 7-l 1 min after rupture of the 















2 100 0 O I 000, 
0 so+ ?i 60 -c 0 0 .s 
d 40 .d + 5 PM diC8 ’ 
H 20 in pipette OO 
000 J 
2 6 10 14 18 22 
time after rupture of patch (min) 
Figure 4. Inclusion of diC8 in the pipette solution promotes “run- 
down” of the sustained Ba2+ current. A, Ba2+ currents recorded at the 
indicated times (2, 10, or 20 min) after rupture of the membrane patch 
to establish the whole-cell recording with a pipette solution containing 
5 PM diC8. All currents were elicited from - 70 mV, with depolarizations 
to + 20 mV. B, Data from the same cell expressed as the percent of the 
initial sustained current that remained during a 23-min recording in the 
presence of internally applied diC8 (open circles). The solid circle (arrow) 
represents the maximum block produced by internally applied diC8 
(mean + SEM; n = 3). The open square represents the fraction of current 
that remained during control recordings performed (in the absence of 
diC8) with 0.1% ethanol or 2 UM dvnornhin A in the Dinette solution 
(mean * SEM; n = 17). For these control experiments, cells were not 
exposed to other drugs. 
patch to allow the inhibitor to diffuse into the cytoplasm. A 
specific inhibitor of PKC, the pseudosubstrate peptide PKCl9- 
36 (2 PM; House and Kemp, 1987), reduced the effect of external 
application of 0.005-5 FM OAG (Figs. 2B, 5) though a higher 
concentration of OAG could overcome the block of sustained 
current in 2 of 4 cells. PKC19-36 reduced the effects of maxi- 
mally effective concentrations of BK (n = 5) and OAG (n = 9) 
by approximately the same extent (6 1% and 58%, respectively; 
Figs. 2B, 5; cf. solid circle and solid bar in Fig. 5). The effects 
of internally applied PKC19-36 were also tested on the inhi- 
bition produced by diC8 in 4 Fl l-B9 cells. In each cell, the 
inhibition of sustained current produced by diC8 was less in the 
presence of inhibitor than the mean response in the absence of 
inhibitor (Fig. 30; cf. open circles to solid circles for 5 and 50 
/IM diC8). When the effects of 5 or 50 PM diC8 on the 4 cells 
recorded in the presence of inhibitor are considered together, 
diC8 was still able to reduce an average of 28% of the sustained 
I control 
.005 .05 .5 5 50 100 nM 
(--- [OAG] PM ---> bradykinin 
Figure 5. Inhibitors of PKC reduce the inhibition of sustained Ba2+ 
current produced by OAG or BK. Dose-response relationships are shown 
to the left for the inhibition of sustained current produced by OAG in 
cells recorded with the control pipette solution (open circles) or pipette 
solution containing the PKC inhibitor 2 PM PKC19-36 (solid circles). 
Each data point is the mean + SEM for 3-10 Fl l-B9 cells. For com- 
parison, the degree of inhibition of sustained current by 100 nM BK is 
shown to the right for recordings performed with the control pipette 
solutions containing either no additions (open bar; n = 25) or 2 PM 
dynorphin A (hatched bar; n = 9). The degree of inhibition produced 
with dynorphin is not significantly different from that produced in the 
absence of any additions (0.05 < p < 0.1, 2-tailed t test). The degree 
of inhibition of sustained current is also shown for recordings performed 
with pipette solutions containing the PKC inhibitors 2 /LM PKC19-36 
(solid bar; n = 5) or 100 nM staurosporine (cross-hatched bar; n = 6). 
The effect of 5 PM OAG or 100 nM BK was significantly reduced by the 
PKC inhibitors (p < 0.01, 2-tailed t test). All bars represent means ? 
SEM. 
current. In summary, 2 I.LM PKC 19-36 reduced but did not abol- 
ish the inhibition of BaZ+ current by 2 PKC activators, OAG 
and diC8, and by BK itself. 
Staurosporine is a potent, nonspecific kinase inhibitor (Hi- 
daka et al., 1984; Tamaoki et al., 1986) that has been used in 
a number of electrophysiological studies (cf. Bosma and Hille, 
1989; Burgess et al., 1989; Conn et al., 1989). The lipid, dis- 
solved in ethanol, was included in the pipette solution at a 
concentration of 100 nM. In the presence of staurosporine, the 
average block produced by a single application of 100 nM BK 
at 7-l 1 min was 13 + 1.9% (Fig. 5, cross-hatched bar; 12 = 6), 
which is significantly different from the degree of block produced 
by single applications of 100 nM BK at 7-l 1 min in control 
recordings in the absence of staurosporine (26 + 3.5% block, n 
= 9; p < 0.01, 2-tailed t test). In addition, in 3 cells the effect 
of staurosporine was measured as the percent inhibition of sus- 
tained current produced by a second exposure to 100 nM BK, 
where the first exposure occurred at 2.54.5 min and the second 
at 9.5-l 1 min after establishing the whole-cell recording. In the 
presence of internally applied staurosporine, a second response 
to BK was reduced by 66.7 f 4.8% when compared to the first 
response to BK in the same cell. 
We performed 3 additional experiments to control for non- 
specific effects of the PKC inhibitors or “chance” reduction in 
the effectiveness of BK and OAG. First, 2 PM dynorphin A was 
used in the pipette solution as a control for nonspecific effects 
of the pseudosubstrate PKCl9-36. These 2 peptides have sim- 
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A 
E 0 %I-diacylglycerol 
not significantly different from the degree of block in the absence 
of dynorphin (Fig. 5, cf. hatched and open bars). Second, in 
some experiments, ethanol (0.1% final concentration) was added 
3, 
2 4.. 1 
g 5-/ 
0 %I-arachidonic acid to the pipette solution as a control for the inclusion of stauro- 
spot-me. In these experiments, a single application of 100 nM BK 
\o at 8-l 1 min blocked 32 f 5.6% of sustained current (n = 3). 
3” 
Third, in all experiments in which a PKC inhibitor was used, 




at least one cell (typically 2-4) was recorded from in the absence 
3;:Ei of inhibitor in order to demonstrate that, with a particular pas- 
se 2 l - sage and plating of F 11 -B9 cells and particular solution of OAG, 
OV QOOo-9-0.::---. BK, or diC8, the typical block of sustained current could be .rl 
a 1 
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I observed in the absence of the PKC inhibitor. 
0 20 40 60 80 100 120 Ba2+ currents of Fl l-B9 cells recorded in the presence of 
100 nM bradykinin exposure (set) internally applied PKC 19-36, staurosporine, dynorphin A, or 
ethanol demonstrated no marked differences in their stability, 
B activation and inactivation profiles, or relative expression of 
15 sec. 
transient and sustained currents, with 1 exception: current-volt- 
s 350.. 
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BK stimulates DAG production in Fll-B9 cells 
E 
1004 -+ : In 9 experiments, the maximal production of 3H-DAG by ex- 
04 -9 -8 -7 -6 -5 
posure to 100 nM BK in a 30 mM Ba2+ external solution was 
log [bradykinin] (M) 
270 ? 22% (mean f SEM) of control. Accumulation of )H- 
DAG upon exposure to 100 nM BK (approximate EC,,) was 
Figure 6. Time course and dose dependence of BK-induced production 
of DAG. Fl 1 -B9 cultures were labeled with ‘H-arachidonic acid for 18- 
24 hr, exposed to BK at 37°C in a buffered solution containing 30 mM 
Ba*+, and extracted for 3H-lipids, as described in Materials and Methods. 
A, Cultures were exposed to 100 nM BK for the time periods indicated. 
Data are presented as the amount of radioactivity (in cpm) in the diglyc- 
eride spot (solid circles) or the arachidonic acid spot (open circles), where 
the region of the TLC plate that was scraped was determined by com- 
igration with authentic lipid standards. Control levels of radioactivity 
were determined after incubation in the buffer solution (minus BK) for 
15, 20, or 30 set and did not differ for these time points (n = 1 l), so 
these data were considered together and plotted on the y-axis at t = 0 
sec. Each data point is the mean k SEM for 3-5 experiments performed 
in duplicate or triplicate, except for the data points at 60, 90, and 120 
set, which represent the average of 2 experiments performed in dupli- 
cate. Cultures contained an average of 499,000 k 22,400 cpm in the 
solvent-extractable lipids (n = 57). Similar experiments performed on 
rat DRG cultures showed comparable results for the production of ‘H- 
DAG when cultures were incubated at 2532, or 37°C. B, Cultures were 
incubated with the indicated concentration of BK for 15 sec. Data for 
3H-DAG production are expressed as percent control, where the control 
consisted of incubation for 15 set in the same buffer solution without 
BK. Each data point is the mean 2 SEM for 3-4 experiments performed 
in duplicate. The EC,, for BK-induced production of ‘H-DAG is about 
40 nM. 
ilar net changes, sizes, and structures, but dynorphin does not 
contain serine or threonine phosphorylation sites. Experiments 
with dynorphin A were performed with the addition of 10 PM 
naloxone to the external solution to prevent activation of opioid 
receptors, if present. Eight of 9 cells (87%) responded to BK in 
the presence of dynorphin A, similar to the 86% response rate 
in the absence of this peptide. After allowing >7 min for dy- 
norphin A to diffuse out of the patch pipette, exposure to 100 
nM BK demonstrated 25 f 4.3% block of sustained BaZ+ current, 
detected at the earliest time point measured (5 set) and returned 
to control levels by 60 set (Fig. 6A). Over a 2-min time course, 
the accumulation of 3H-DAG occurred in one distinct phase 
with a peak near 15 sec. Interestingly, in the same extracts, Fl l- 
B9 cells did not liberate appreciable amounts of 3H-arachidonic 
acid upon exposure to BK (Fig. 6A). The maximal accumulation 
of arachidonic acid after a 15- or 20-set incubation with 100 
nM BK was 112 f 9% of control (n = 9). Data points in Figure 
6A represent the means f SEM for 3-5 separate experiments 
periormed in duplicate or triplicate, except for the 60-, 90-, and 
120-set time points, which represent the average of 2 experi- 
ments. Data are expressed as radioactivity present in 3H-DAG 
or 3H-arachidonic acid after exposure to BK or the external 
solution alone. 
The increase by BK (15-set exposure) of 3H-DAG production 
was concentration dependent, with a threshold near 3 nM and 
maximal accumulation occurring near 1 PM (Fig. 6B). Half- 
maximal production of DAG occurred at about 40 nM BK, 
similar to the IC,, for BK block of the Ba2+ currents (Fig. 1D). 
The range of effective BK concentrations also approximates 
those reported for the BK-induced stimulation of IP, in the 
parent F-l 1 cell line (France1 et al., 1987b, 1989). Data points 
in Figure 6B represent the mean f SEM for 3-4 experiments 
performed in duplicate and are expressed as a percent of the 
levels of 3H-DAG found in control extracts from the same ex- 
periment. 
Discussion 
Evidence for a role of PKC in the regulation of sustained 
barium current 
Several lines of evidence support the idea that PKC is a likely 
mediator of the BK-induced reduction of voltage-activated sus- 
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tamed BaZ+ current in a DRG cell line, Fl l-B9. We have dem- 
onstrated elevation of a radiolabeled pool of DAG which is an 
endogenous activator of PKC, as well as simulation of the BK 
effect by membrane-permeable activators of PKC and blockade 
of the BK reduction of Ca2+ channel current by PKC inhibitors. 
One requirement for implicating a second messenger in the 
regulation of an ion channel is that the properties of agonist- 
induced formation of second messenger should be similar to the 
agonist-induced modulation of channel function. Similarity in 
the concentration dependence of the inhibition of sustained Ba2+ 
current (Fig. 1D) and accumulation of 3H-DAG (Fig. 6B) by 
BK exposure to Fl l-B9 cells is consistent with the hypothesis 
that these 2 effects are related. It is important to note that 3H- 
DAG production induced by BK was measured under ionic 
conditions similar to those used for the physiological recordings 
of inhibition of Ba2+ current. Furthermore, 3H-DAG production 
induced by BK is rapid enough (Fig. 6A) to account for the 
inhibition of Ba2+ current, which occurs within a few seconds. 
While DAG is not the only endogenous activator of PKC (Nishi- 
zuka, 1984; Kikkawa and Nishizuka, 1986), all PKC isozymes 
described thus far require DAG for full activation in vitro (Mu- 
rakami et al., 1986; Huang et al., 1988; Nishizuka, 1988; Naor 
et al., 1988). 
The ability of DAG analogs OAG and diC8 to inhibit sus- 
tained Ba*+ current (Figs. 2, 3) is consistent with a role for PKC 
in the inhibition of this current. The effective concentration 
ranges of OAG and diC8 correspond well with concentrations 
used to activate PKC in cell-free enzymatic assays (Ganong et 
al., 1986) and concentrations used to modulate ion channel 
function in other cell types (DeRiemer et al., 1985; Rane and 
Dunlap, 1986; Hammond et al., 1987; Doemer et al., 1988; 
Marchetti and Brown, 1988; Vivaudou et al., 1988; Bosma and 
Hille, 1989). EGD, a structural analog of diC8 that does not 
activate PKC (Bishop and Bell, 1986; Ganong et al., 1986) was 
less effective as an inhibitor of sustained Ba2+ current in Fl l- 
B9 cells (Fig. 3B,D). Additional evidence for a role for PKC is 
the ability of inhibitors of PKC to reduce the effects of activators 
of PKC and BK itself on the sustained Ba2+ current. The PKC 
inhibitor PKC 19-36 (2 PM in pipette) reduced the effects of 
maximal concentrations of OAG and BK by the same extent, 
nearly 60% (Fig. 5). The nonspecific kinase inhibitor staurospo- 
rine (100 nM in pipette) also reduced the response to 100 nM 
BK by about 55% (Fig. 5). 
The evidence that PKC regulates the sustained Ba2+ current 
in Fl 1 -B9 cells is thus convergent, but it is circumstantial. The 
strength of these interpretations depends on the specificity of 
the pharmacological tools used to investigate this pathway, 
namely, OAG, diC8, EGD, and the inhibitors PKC19-36 and 
staurosporine. Although the specificity of these drugs has been 
characterized in cell-free enzymatic assays (Ebeling et al., 1985; 
Bishop and Bell, 1986; Ganong et al., 1986; House and Kemp, 
1987), their specific actions are difficult to determine under more 
physiological conditions. In addition, it is not known whether 
the PKC activators or the inhibitors preferentially act on certain 
PKC isozymes. Peptide inhibitors of PKC, such as PKC 19-3 1 
and PKC19-36, have been used by only 2 other groups per- 
forming whole-cell patch-clamp experiments. In both cases 
(Bosma and Hille, 1989; Rane et al., 1989), the peptide inhibitor 
reduced the effect of an exogenous activator of PKC (OAG or 
phorbol ester) on an ionic current. In comparison with lipid 
inhibitors of PKC, such as staurosporine and sphingosine (e.g., 
Doemer et al., 1988; Conn et al., 1989) peptide inhibitors have 
been recently introduced, and there is even less information 
available on their actions unrelated to PKC. Dynorphin A has 
a similar amino acid composition, molecular weight, and net 
charge as PKC19-36, so we used this peptide as a control for 
nonspecific effects of PKC19-36 due, for example, to its highly 
basic nature. Dynorphin A applied to Fl 1 -B9 cells in the pipette 
solution (2 PM) did not inhibit the effect of 100 nM BK on the 
current (Fig. 5) and did not alter any properties of the sustained 
Ba2+ current in Fl l-B9 cells. 
A major limitation of both the electrophysiological experi- 
ments performed on single chick DRG neurons (Rane et al., 
1989) and single Fl l-B9 cells is the inability to measure changes 
in PKC activity in the very cell exposed to the activator or 
inhibitor of PKC. More compelling evidence for a role for PKC 
in the BK-mediated reduction of sustained Ba2+ current in F ll- 
B9 cells would require information about the subspecies of PKC 
present in Fl 1 -B9 cells and the specific activation characteristics 
of these isozymes, followed by reconstitution of the components 
of the transduction pathway into lipid bilayers. 
Comparison of the effects of DAG analogs 
The effect of diC8 on sustained Ba2+ current in Fl 1 -B9 cells was 
clearly different from that produced by both OAG and BK. Most 
of the sustained current (range, 74-98%) could be blocked by 
5-50 PM diC8, whereas both OAG and BK produced a maxi- 
mum of about 30% reduction. This indicates that the 2 DAG 
analogs differ in either their efficacy or their specificity of stim- 
ulation of PKC. Differences in efficacy might be achieved by 
differences in the rate or extent of degradation in the cytoplasm, 
solubility in the membrane, access to PKC, or preferential ac- 
tivation of certain isozymes of PKC. It is also possible that 
OAG and BK activate (indirectly) protein phosphatases but that 
diC8 does not. These possibilities were not addressed in our 
study. 
Unlike a number of other membrane-permeable activators of 
PKC, high concentrations of diC8 (> 12.5 FM) are reported to 
induce cytosolic acidification and release of intracellular Ca2+ 
in lymphocytes (Ebanks et al., 1989). These effects of diC8 were 
not blocked by chronic exposure to phorbol ester (Ebanks et al., 
1989) which was expected to downregulate PKC. Because of 
the high H+ and Ca2+ ,buffering capacity of the pipette solution 
used in the present study, it is not expected that diC8 would 
cause acidification or release of intracellular Ca2+, but such ef- 
fects cannot be ruled out by our data. 
Modulation of d&erent channels by BK may occur through a 
common PKC pathway 
As discussed previously, BK is reported to block whole-cell Ca2+ 
currents in cultured rat DRG neurons (Ewald et al., 1989; but 
see Dolphin et al., 1989) as well as in Fl l-B9 cells. In current- 
clamp recordings, BK depolarizes a subpopulation of DRG neu- 
rons (Baccaglini and Hogan, 1983; McGehee and Oxford, 1988, 
1989; Burgess et al., 1989). This depolarization is likely caused 
by the opening of a nonselective monovalent cation channel, as 
recorded under voltage-clamp conditions (Burgess et al., 1989). 
The depolarization (and spiking) produced by BK appears to 
be sufficient to induce the opening of the high-threshold, dihy- 
dropyridine-sensitive, L-type Ca2+ channels because the BK- 
induced influx of radiolabeled 45Ca is markediy reduced by 
nifedipine (Burgess et al., 1989). This evidence suggests the 
following course of events: In a non-voltage-clamped DRG neu- 
ron, BK-receptor activation first opens channels that allow the 
1148 Boland et al. - Inhibition of Barium Current in a DRG Cell Line 
influx of Na+ that depolarizes the cell, causing action potential 
generation and thus the opening of voltage-activated Ca*+ chan- 
nels. The increase in 45Ca flux measured upon exposure to BK 
(Burgess et al., 1989) is a secondary effect of the depolarization; 
there is no evidence that BK directly activates Ca*+ channels. 
A fraction of the Ca2+ channels opened by the membrane de- 
polarization are subsequently blocked by the exposure to BK. 
In this sense, the inhibition of Ca2+ current by BK may serve a 
homeostatic role, damping the effects of depolarization on trans- 
mitter release. 
The findings of Burgess et al. (1989) raise the possibility that 
PKC regulates the monovalent cation channels that are opened 
upon exposure to BK. Phorbol esters mimicked the ability of 
BK to depolarize DRG neurons, and both phorbol esters and 
OAG (1 PM) mimicked the BK-induced increase in the rate of 
uptake of 45Ca. All of these effects were nearly completely blocked 
by the PKC inhibitor staurosporine and by downregulation of 
PKC by long-term phorbol ester pretreatment. These data, along 
with the present study, suggest that the BK-induced depolar- 
ization measured in current clamp and the BK-induced reduc- 
tion of Ca2+ current measured in voltage clamp are both me- 
diated by PKC activation. If so, BK may provide a good example 
of how multiple cellular actions of a neurotransmitter (Miller, 
1987) can be produced by activation of one kinase pathway. 
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